ijms-logo

Journal Browser

Journal Browser

New Insights into Lactoferrin: 2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 20 April 2026 | Viewed by 962

Special Issue Editors

Special Issue Information

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue, entitled “New Insights into Lactoferrin” (https://www.mdpi.com/journal/ijms/special_issues/603A0C5W43).

Lactoferrin (Lf), a positively charged glycoprotein known for its iron-binding capacity, is produced by the exocrine glands and neutrophils. Due to its role in innate immunity, Lf exerts antibacterial, antiviral, antiparasitic, antifungal, antioxidant, anti-inflammatory, immunomodulatory and anticancer effects. The physicochemical characteristics of Lf can greatly impact its functionality, which can be influenced by species-specific and tissue-specific factors, as well as environmental conditions. Importantly, Lf could be utilized in the prevention and treatment of various pathological conditions, thus gaining recognition as a nutraceutical and as a carrier for the delivery of biologically active compounds.

This Special Issue is supervised by Dr. Antimo Cutone and Prof. Dr. Giovanni Musci, with assistance from our Topical Advisory Panel Member, Dr. Giusi Ianiro. It aims to provide a thorough overview of the biochemical, molecular and physiological aspects of Lf biology and its application in both healthy and those with pathologies. The scope of this Special Issue includes the structural and functional properties of Lf, its role in the prevention and treatment of disease, as well as the development of new biotechnologies that aim to enhance the production, bioavailability and functionality of Lf. We welcome the submission of original research articles and reviews.

Dr. Antimo Cutone
Prof. Dr. Giovanni Musci
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lactoferrin
  • lactoferrin structure
  • lactoferrin functions
  • infection
  • inflammation
  • iron homeostasis
  • oxidative stress
  • lactoferrin bioavailability

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 1321 KB  
Article
Lactoferrin and Thioredoxin in Rheumatoid Arthritis Are Associated with Fibrinogen but Not with Other Acute Phase Proteins
by Ginka Delcheva, Katya Stefanova, Pavel Selimov and Teodora Stankova
Int. J. Mol. Sci. 2025, 26(17), 8211; https://doi.org/10.3390/ijms26178211 - 24 Aug 2025
Viewed by 603
Abstract
Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases which global prevalence is approximately 0.3–2%. Numerous studies provide evidence that the elevated levels of reactive oxygen species (ROS) contribute to the pathogenesis and progression of RA. In response to redox [...] Read more.
Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases which global prevalence is approximately 0.3–2%. Numerous studies provide evidence that the elevated levels of reactive oxygen species (ROS) contribute to the pathogenesis and progression of RA. In response to redox imbalance, several intrinsic antioxidant defence mechanisms are activated to counteract oxidative stress and scavenge ROS. The aim of the present study is to analyse whether the levels of lactoferrin and thioredoxin, two proteins which are part of the antioxidant defence of the body, are associated with fibrinogen and other acute phase proteins such as CRP and ferritin in RA. Serum lactoferrin, thioredoxin, ferritin, and CRP levels were measured using ELISA. Significant positive correlations of lactoferrin and thioredoxin with fibrinogen were observed in RA patients, r = 0.394, p < 0.0001 and r = 0.410, p = 0.002, respectively. These positive correlations were also observed in females, r = 0.375, p < 0.0001 and r = 0.447, p = 0.001, in the subgroup of patients with DAS28 < 5.1, r = 0.689, p < 0.0001 and r = 0.604, p = 0.001 and in the subgroup of patients with normal CRP, r = 0.488, p < 0.0001 and r = 0.414, p = 0.005, respectively. These findings help clarify the pathogenetic interplay between oxidative stress, inflammation, and coagulation in RA and indicate the need for further studies to elucidate the potential of lactoferrin and thioredoxin as biomarkers that capture pathological disease changes. Full article
(This article belongs to the Special Issue New Insights into Lactoferrin: 2nd Edition)
Show Figures

Figure 1

Back to TopTop